Acadia Healthcare Company, Inc.
| Company Name | Acadia Healthcare Company, Inc. |
| Stock Symbol | ACHC |
On December 2, 2025, after market hours, Acadia disclosed that “following its annual, third-party actuarial review of anticipated PLGL costs,” the Company expected higher expenses “associated primarily with patient-related litigation” and “now expects full-year 2025 Adjusted EBITDA in the range of $601 million to $611 million, compared to its prior guidance of $650 million to $660 million.” Additionally, the Company “now projects 2025 PLGL expense of approximately $116 million, compared to $54 million in 2024, representing a year-over-year increase of approximately $62 million” due primarily to higher expected settlement costs for claims, a significant increase in claim frequency, elevated incurred-but-not-reported reserves, and “[less] favorable reinsurance coverage terms versus prior years.”
On this news, Acadia’s stock price fell $1.80, or 10.9%, to close at $14.69 on December 3, 2025, thereby injuring investors.
Submit Your Information
If you suffered a loss on your Acadia Healthcare Company, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.